8-K//Current report
Inmune Bio, Inc. 8-K
Accession 0001213900-25-123880
$INMBCIK 0001711754operating
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:30 PM ET
Size
521.2 KB
Accession
0001213900-25-123880
Documents
- 8-Kea0269963-8k_inmune.htmPrimary
CURRENT REPORT
- EX-1.1ea026996301ex1-1_inmune.htm
SALES AGREEMENT, DATED DECEMBER 19, 2025, BY AND BETWEEN INMUNE BIO INC. AND A.G.P./ALLIANCE GLOBAL PARTNERS
- EX-5.1ea026996301ex5-1_inmune.htm
OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP
- GRAPHICex5-1_001.jpg
GRAPHIC
- EX-101.SCHinmb-20251219.xsd
XBRL SCHEMA FILE
- EX-101.LABinmb-20251219_lab.xml
XBRL LABEL FILE
- EX-101.PREinmb-20251219_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-123880-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0269963-8k_inmune_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001711754
Filing Metadata
- Form type
- 8-K
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:30 PM ET
- Size
- 521.2 KB